Reports

Ideas That Generate Results

1. Analyst View

2. Global Protein Therapeutics Market
     2.1 Market Analysis
             2.1.1 Market Size
             2.1.2 Protein Therapeutics Market vs Pharmaceutical Market
             2.1.3 Market Segmentation
     2.2 Future Outlook (2012-2014)

3. Industry Performance
     3.1 Monoclonal Antibodies (mAbs)
            3.1.1 Market Size
            3.1.2 By Application
            3.1.3 Key Geographical Markets
            3.1.4 Key Players and Drugs
            3.1.5 Industry Analysis
            3.1.6 Recent Developments
            3.1.7 Future Outlook (2012-2014)
     3.2 Erythropoietin (EPO)
            3.2.1 Market Size
            3.2.2 By Application
            3.2.3 Key Geographical Markets
            3.2.4 Key Players and Drugs
            3.2.5 Industry Analysis
            3.2.6 Recent Developments
            3.2.7 Future Outlook (2012-2014)
     3.3 Insulin
            3.3.1 Market Size
            3.3.2 By Application
            3.3.3 Key Geographical Markets
            3.3.4 Key Players and Drugs
            3.3.5 Industry Analysis
            3.3.6 Recent Developments
            3.3.7 Future Outlook (2012-2014)
     3.4 Interferon (IFN)
            3.4.1 Market Size
            3.4.2 Key Geographical Markets
            3.4.3 Key Players and Drugs
            3.4.4 Industry Analysis
            3.4.5 Recent Developments
            3.4.6 Future Outlook (2012-2014)
     3.5 Human Growth Hormone (HGH)
            3.5.1 Market Size
            3.5.2 By Application
            3.5.3 Key Geographical Markets
            3.5.4 Key Players and Drugs
            3.5.5 Industry Analysis
            3.5.6 Recent Developments
            3.5.7 Future Outlook (2012-2014)
     3.6 Blood Clotting Factor
            3.6.1 Market Size
            3.6.2 Key Players and Drugs
            3.6.3 Industry Analysis
            3.6.4 Recent Developments
            3.6.5 Future Outlook (2012-2014)
     3.7 Follicle Stimulating Hormone (FSH)
            3.7.1 Market Size
            3.7.2 Key Players and Drugs
            3.7.3 Industry Analysis
            3.7.4 Future Outlook (2012-2014)
     3.8 Granulocyte Colony Stimulating Factor (G-CSF)
            3.8.1 Market Size
            3.8.2 Key Players and Drugs
            3.8.3 Industry Analysis
            3.8.4 Future Outlook (2012-2014)

4. Emerging Market Trends
     4.1 Synthetic Biology: Taking Command of the Industry
     4.2 Drug-like Protein Therapies: Increasing Stability
     4.3 Effective Delivery Methods: Improving the Reach of Therapies
     4.4 Tackling Immunogenicity Issues: Ensuring Product Safety
     4.5 Multifunctional Proteins: Targeting Wider Range of Diseases

5. Key Players
     5.1 Johnson & Johnson
     5.2 Biogen Idec Inc.
     5.3 Eli Lilly & Company
     5.4 Sanofi-Aventis
     5.5 Merck Serono S.A.
     5.6 Roche Group
     5.7 Amgen Inc.